<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药事纵横 | wechat-feeds</title><link>http://MzI5ODI5NDE2OA.favicon.privacyhide.com/favicon.ico</link><description>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 01 Feb 2021 12:07:45 +0800</pubDate><image><url>http://MzI5ODI5NDE2OA.favicon.privacyhide.com/favicon.ico</url><title>药事纵横 | wechat-feeds</title><link>http://MzI5ODI5NDE2OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>从独眼羊到抗癌新药</title><link>https://mp.weixin.qq.com/s/uISlu0j611xQj0_ta_TyXQ</link><description></description><content:encoded><![CDATA[从独眼羊到抗癌新药]]></content:encoded><pubDate>Mon, 01 Feb 2021 09:02:08 +0800</pubDate></item><item><title>PROTAC技术详梳理-2-分子与结构机理篇</title><link>https://mp.weixin.qq.com/s/IP1IFs0l_GHz-H4tl9Uk_g</link><description></description><content:encoded><![CDATA[PROTAC技术详梳理-2-分子与结构机理篇]]></content:encoded><pubDate>Mon, 01 Feb 2021 09:02:08 +0800</pubDate></item><item><title>高效液相检验时重复样与进针次数讨论</title><link>https://mp.weixin.qq.com/s/ICfYLanaQg2PymKXd9rxxg</link><description></description><content:encoded><![CDATA[高效液相检验时重复样与进针次数讨论]]></content:encoded><pubDate>Mon, 01 Feb 2021 09:02:08 +0800</pubDate></item><item><title>药事纵横征稿启事</title><link>https://mp.weixin.qq.com/s/ZIuXFkneiZ1PaZlYavvqYg</link><description></description><content:encoded><![CDATA[药事纵横征稿启事]]></content:encoded><pubDate>Mon, 01 Feb 2021 09:02:08 +0800</pubDate></item><item><title>FDA批准的老药新用案例总结：创新药太贵，就试试老药二次创新</title><link>https://mp.weixin.qq.com/s/b7p8aArl9ErOK-Z1S8YiDQ</link><description></description><content:encoded><![CDATA[FDA批准的老药新用案例总结：创新药太贵，就试试老药二次创新]]></content:encoded><pubDate>Sat, 30 Jan 2021 22:09:59 +0800</pubDate></item><item><title>新公众号“药海书香”，期待各位大佬的关注</title><link>https://mp.weixin.qq.com/s/e2LfeaBTvDBeG3aEDUYhoQ</link><description></description><content:encoded><![CDATA[新公众号“药海书香”，期待各位大佬的关注]]></content:encoded><pubDate>Sat, 30 Jan 2021 22:09:59 +0800</pubDate></item><item><title>罗氏全球首款针对眼疾的双特异性抗体Faricimab III期临床效果显著！疗效更持久</title><link>https://mp.weixin.qq.com/s/XM_pMN_yxjC8Kz1RVdzQcQ</link><description></description><content:encoded><![CDATA[罗氏全球首款针对眼疾的双特异性抗体Faricimab III期临床效果显著！疗效更持久]]></content:encoded><pubDate>Sat, 30 Jan 2021 08:53:36 +0800</pubDate></item><item><title>那些集采超低价品种，销售咋样了？</title><link>https://mp.weixin.qq.com/s/uhLjxylkcRdP79YoPL66tw</link><description></description><content:encoded><![CDATA[那些集采超低价品种，销售咋样了？]]></content:encoded><pubDate>Sat, 30 Jan 2021 08:53:36 +0800</pubDate></item><item><title>新公众号“药海书香”，期待各位大佬的关注</title><link>https://mp.weixin.qq.com/s/b25-RkHMQG2oRGPnxu-zMQ</link><description></description><content:encoded><![CDATA[新公众号“药海书香”，期待各位大佬的关注]]></content:encoded><pubDate>Sat, 30 Jan 2021 08:53:36 +0800</pubDate></item><item><title>每个人都应读一读：国务院发布关于推动药品集中带量采购工作常态化制度化开展的意见</title><link>https://mp.weixin.qq.com/s/taoZ-7Baf7Wuq7NZh73Trg</link><description></description><content:encoded><![CDATA[每个人都应读一读：国务院发布关于推动药品集中带量采购工作常态化制度化开展的意见]]></content:encoded><pubDate>Fri, 29 Jan 2021 09:08:56 +0800</pubDate></item><item><title>FDA批准新型口服免疫抑制剂，用于狼疮性肾炎治疗</title><link>https://mp.weixin.qq.com/s/8Zf6hO7pmtHnWP_f93DiIA</link><description></description><content:encoded><![CDATA[FDA批准新型口服免疫抑制剂，用于狼疮性肾炎治疗]]></content:encoded><pubDate>Fri, 29 Jan 2021 09:08:56 +0800</pubDate></item><item><title>分析方法开发：影响关键色谱峰对分离度的三个重要因素</title><link>https://mp.weixin.qq.com/s/L7MCbREEucsXljOZgOBJ-A</link><description></description><content:encoded><![CDATA[分析方法开发：影响关键色谱峰对分离度的三个重要因素]]></content:encoded><pubDate>Fri, 29 Jan 2021 09:08:56 +0800</pubDate></item><item><title>药事纵横征稿启事</title><link>https://mp.weixin.qq.com/s/9VKW-NnVkZUr1wGyUtyBOA</link><description></description><content:encoded><![CDATA[药事纵横征稿启事]]></content:encoded><pubDate>Fri, 29 Jan 2021 09:08:56 +0800</pubDate></item><item><title>关于肠溶制剂溶出曲线相似性评估的几点看法</title><link>https://mp.weixin.qq.com/s/iRx6V8E9sQ95Y7cqPxOm7g</link><description></description><content:encoded><![CDATA[关于肠溶制剂溶出曲线相似性评估的几点看法]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:29:46 +0800</pubDate></item><item><title>那些集采中标价还凑合的品种，销售咋样了？</title><link>https://mp.weixin.qq.com/s/6Rg6KNyk_CqeFIBxS3WyyQ</link><description></description><content:encoded><![CDATA[那些集采中标价还凑合的品种，销售咋样了？]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:29:46 +0800</pubDate></item><item><title>化学药品粒度、纤维长度和粒径分布检测指南</title><link>https://mp.weixin.qq.com/s/uA1AFBHAHn6BsmN5wKzDPQ</link><description></description><content:encoded><![CDATA[化学药品粒度、纤维长度和粒径分布检测指南]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:29:46 +0800</pubDate></item><item><title>药事纵横广告投放须知</title><link>https://mp.weixin.qq.com/s/_6LxzW18mDdCj_ANFVqOMQ</link><description></description><content:encoded><![CDATA[药事纵横广告投放须知]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:29:46 +0800</pubDate></item><item><title>第五个产品Molidustat获批，HIF-PH抑制剂竞争将很快白热化</title><link>https://mp.weixin.qq.com/s/yKSwKu-DI6DtmF1ya6gh9A</link><description></description><content:encoded><![CDATA[第五个产品Molidustat获批，HIF-PH抑制剂竞争将很快白热化]]></content:encoded><pubDate>Tue, 26 Jan 2021 23:05:41 +0800</pubDate></item><item><title>课程报名 | 保护药品研发成果，这2项专利制度你必须知道！</title><link>https://mp.weixin.qq.com/s/Ivu18qttPDqh42XbkYQiAQ</link><description></description><content:encoded><![CDATA[课程报名 | 保护药品研发成果，这2项专利制度你必须知道！]]></content:encoded><pubDate>Tue, 26 Jan 2021 23:05:41 +0800</pubDate></item><item><title>光学显微镜在制药中的应用浅析</title><link>https://mp.weixin.qq.com/s/P4bJuuG3kqSHJJvsE-bi-w</link><description></description><content:encoded><![CDATA[光学显微镜在制药中的应用浅析]]></content:encoded><pubDate>Tue, 26 Jan 2021 23:05:41 +0800</pubDate></item></channel></rss>